Thursday, February 1, 2007

Alembic buys non-oncology division of Dabur Pharma

Alembic has acquired the domestic non-oncology formulation business of Dabur Pharma for a consideration of Rs. 159 crores. The acquisition will be funded through a combination of internal accruals and debt. The company may also exercise the option of diluting a small portion of its equity. The consideration of Rs. 159 crores is for the acquisition plus the actual net working capital.

Read the article.

No comments: